Current FDA approval of this adaptive system is for the treatment of Parkinson’s only, not essential tremor, dystonia (a ...

It's an honor to be a part of this process to, as a basic scientist, be able to play a small role in improving the lives of ...

Twenty-eight years later, as a political science professor emeritus at Stanford, Krehbiel just became the first person in the ...

The Italian neuromodulation startup Newronika has secured a European approval for its closed-loop, adaptive implant for ...

Abbott Neuromodulation's Jenn Wong discusses the TRANSCEND trial for depression, imaging tech advancing DBS and other ...

In 2022, the brain implants market was valued at over USD 5.7 billion, and its rapid expansion is fueled by several key factors. One of the most significant drivers is the rising incidence of nervous ...

Parkinson's disease patients and advocates are marking Friday as the start of a new era for treatment of the illness as a ...

A small pilot study has shown that deep brain stimulation (DBS), a surgical treatment that delivers electrical signals to ...

A revolutionary trial for a brain-pacemaker implant is seeking to become a potential new treatment for alcohol and drug ...

In the sixth episode of The Deep End, listen to what’s next for Jon Nelson and for deep brain stimulation research for depression.

The brain implants market is projected to grow from US$ 7.21 billion in 2022 to US$ 17.65 billion by 2030, at a CAGR of 11.8% ...